TOFIDENCE(tocilizumab-bavi), is a treatment developed as a biosimilar to the reference product ACTEMRA. TOFIDENCE is indicated for the treatment of moderately toseverely active rheumatoid arthritis, polyarticular juvenile idiopathicarthritis and systemic juvenile idiopathic arthritis in the US and EU.
Prescribing InformationTOFIDENCE™®